Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions

doi:10.3389/fphar.2021.665936

Editorial

. 2021 Apr 26:12:665936.

doi: 10.3389/fphar.2021.665936. eCollection 2021.

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions

Ya Liu¹, Xiongwen Chen², Hai-Gang Zhang¹

Affiliations

¹ Department of Pharmacology, Army Medical University (Third Military Medical University), Chongqing, China.
² Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.

PMID: 33981242
PMCID: PMC8107717
DOI: 10.3389/fphar.2021.665936

Editorial

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions

Ya Liu et al. Front Pharmacol. 2021.

. 2021 Apr 26:12:665936.

doi: 10.3389/fphar.2021.665936. eCollection 2021.

Authors

Ya Liu¹, Xiongwen Chen², Hai-Gang Zhang¹

Affiliations

¹ Department of Pharmacology, Army Medical University (Third Military Medical University), Chongqing, China.
² Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.

PMID: 33981242
PMCID: PMC8107717
DOI: 10.3389/fphar.2021.665936

No abstract available

Keywords: cardiac fibrosis; cardiac hypertrophy; cardiac remodeling; heart failure; heart function.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Cited by

Asporin, an extracellular matrix protein, is a beneficial regulator of cardiac remodeling.
Huang C, Sharma A, Thakur R, Rai D, Katiki M, Germano JF, Song Y, Singh S, Sin J, Sengstock D, Andres AM, Murali R, Mentzer RM Jr, Gottlieb RA, Piplani H. Huang C, et al. Matrix Biol. 2022 Jun;110:40-59. doi: 10.1016/j.matbio.2022.04.005. Epub 2022 Apr 22. Matrix Biol. 2022. PMID: 35470068 Free PMC article.
USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality.
Jean-Charles PY, Roy B, Yu SM, Pironti G, Nagi K, Mao L, Kaur S, Abraham DM, Maudsley S, Rockman HA, Shenoy SK. Jean-Charles PY, et al. Am J Physiol Heart Circ Physiol. 2024 Nov 1;327(5):H1257-H1271. doi: 10.1152/ajpheart.00329.2024. Epub 2024 Oct 4. Am J Physiol Heart Circ Physiol. 2024. PMID: 39365672
Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling.
Hong JH, Zhang HG. Hong JH, et al. Front Pharmacol. 2022 Feb 2;13:828549. doi: 10.3389/fphar.2022.828549. eCollection 2022. Front Pharmacol. 2022. PMID: 35185581 Free PMC article. Review.
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
Liang Q, Xu H, Liu M, Qian L, Yan J, Yang G, Chen L. Liang Q, et al. J Am Heart Assoc. 2022 Jul 5;11(13):e025021. doi: 10.1161/JAHA.121.025021. Epub 2022 Jun 22. J Am Heart Assoc. 2022. PMID: 35730615 Free PMC article.

References

1. Di Palo K. E., Barone N. J. (2020). Hypertension and Heart Failure. Heart Fail. Clin. 16 (1), 99–106. 10.1016/j.hfc.2019.09.001 - DOI - PubMed
1. Dodge-Kafka K., Gildart M., Tokarski K., Kapiloff M. S. (2019). mAKAPβ Signalosomes - A Nodal Regulator of Gene Transcription Associated with Pathological Cardiac Remodeling. Cell. Signal. 63, 109357. 10.1016/j.cellsig.2019.109357 - DOI - PMC - PubMed
1. Ge W., Hou C., Zhang W., Guo X., Gao P., Song X., et al. (2021). Mep1a Contributes to Ang II-Induced Cardiac Remodeling by Promoting Cardiac Hypertrophy, Fibrosis and Inflammation. J. Mol. Cell Cardiol. 152, 52–68. 10.1016/j.yjmcc.2020.11.015 - DOI - PubMed
1. He J., Luo Y., Song J., Tan T., Zhu H. (2020). Non-coding RNAs and Pathological Cardiac Hypertrophy. Adv. Exp. Med. Biol. 1229, 231–245. 10.1007/978-981-15-1671-9_13 - DOI - PubMed
1. Heger J., Schulz R., Euler G. (2016). Molecular Switches under TGFβ Signalling during Progression from Cardiac Hypertrophy to Heart Failure. Br. J. Pharmacol. 173 (1), 3–14. 10.1111/bph.13344 - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Di Palo K. E., Barone N. J. (2020). Hypertension and Heart Failure. Heart Fail. Clin. 16 (1), 99–106. 10.1016/j.hfc.2019.09.001 - DOI - PubMed

[2] Di Palo K. E., Barone N. J. (2020). Hypertension and Heart Failure. Heart Fail. Clin. 16 (1), 99–106. 10.1016/j.hfc.2019.09.001 - DOI - PubMed

[3] Dodge-Kafka K., Gildart M., Tokarski K., Kapiloff M. S. (2019). mAKAPβ Signalosomes - A Nodal Regulator of Gene Transcription Associated with Pathological Cardiac Remodeling. Cell. Signal. 63, 109357. 10.1016/j.cellsig.2019.109357 - DOI - PMC - PubMed

[4] Dodge-Kafka K., Gildart M., Tokarski K., Kapiloff M. S. (2019). mAKAPβ Signalosomes - A Nodal Regulator of Gene Transcription Associated with Pathological Cardiac Remodeling. Cell. Signal. 63, 109357. 10.1016/j.cellsig.2019.109357 - DOI - PMC - PubMed

[5] Ge W., Hou C., Zhang W., Guo X., Gao P., Song X., et al. (2021). Mep1a Contributes to Ang II-Induced Cardiac Remodeling by Promoting Cardiac Hypertrophy, Fibrosis and Inflammation. J. Mol. Cell Cardiol. 152, 52–68. 10.1016/j.yjmcc.2020.11.015 - DOI - PubMed

[6] Ge W., Hou C., Zhang W., Guo X., Gao P., Song X., et al. (2021). Mep1a Contributes to Ang II-Induced Cardiac Remodeling by Promoting Cardiac Hypertrophy, Fibrosis and Inflammation. J. Mol. Cell Cardiol. 152, 52–68. 10.1016/j.yjmcc.2020.11.015 - DOI - PubMed

[7] He J., Luo Y., Song J., Tan T., Zhu H. (2020). Non-coding RNAs and Pathological Cardiac Hypertrophy. Adv. Exp. Med. Biol. 1229, 231–245. 10.1007/978-981-15-1671-9_13 - DOI - PubMed

[8] He J., Luo Y., Song J., Tan T., Zhu H. (2020). Non-coding RNAs and Pathological Cardiac Hypertrophy. Adv. Exp. Med. Biol. 1229, 231–245. 10.1007/978-981-15-1671-9_13 - DOI - PubMed

[9] Heger J., Schulz R., Euler G. (2016). Molecular Switches under TGFβ Signalling during Progression from Cardiac Hypertrophy to Heart Failure. Br. J. Pharmacol. 173 (1), 3–14. 10.1111/bph.13344 - DOI - PMC - PubMed

[10] Heger J., Schulz R., Euler G. (2016). Molecular Switches under TGFβ Signalling during Progression from Cardiac Hypertrophy to Heart Failure. Br. J. Pharmacol. 173 (1), 3–14. 10.1111/bph.13344 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions

Affiliations

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources